Correlation Between Pacira BioSciences, and Assertio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Assertio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Assertio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Assertio Therapeutics, you can compare the effects of market volatilities on Pacira BioSciences, and Assertio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Assertio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Assertio Therapeutics.
Diversification Opportunities for Pacira BioSciences, and Assertio Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pacira and Assertio is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Assertio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assertio Therapeutics and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Assertio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assertio Therapeutics has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Assertio Therapeutics go up and down completely randomly.
Pair Corralation between Pacira BioSciences, and Assertio Therapeutics
Given the investment horizon of 90 days Pacira BioSciences, is expected to generate 0.31 times more return on investment than Assertio Therapeutics. However, Pacira BioSciences, is 3.23 times less risky than Assertio Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Assertio Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 1,713 in Pacira BioSciences, on August 28, 2024 and sell it today you would earn a total of 29.00 from holding Pacira BioSciences, or generate 1.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pacira BioSciences, vs. Assertio Therapeutics
Performance |
| Timeline |
| Pacira BioSciences, |
| Assertio Therapeutics |
Pacira BioSciences, and Assertio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pacira BioSciences, and Assertio Therapeutics
The main advantage of trading using opposite Pacira BioSciences, and Assertio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Assertio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assertio Therapeutics will offset losses from the drop in Assertio Therapeutics' long position.| Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
| Assertio Therapeutics vs. Amneal Pharmaceuticals, Class | Assertio Therapeutics vs. Lifecore Biomedical | Assertio Therapeutics vs. Ironwood Pharmaceuticals | Assertio Therapeutics vs. Neurocrine Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |